Open Access

Aged garlic extract and S-allylcysteine prevent apoptotic cell death in a chemical hypoxia model

  • Marisol Orozco-Ibarra1,
  • Jorge Muñoz-Sánchez2,
  • Martín E. Zavala-Medina2,
  • Benjamín Pineda3,
  • Roxana Magaña-Maldonado3,
  • Edgar Vázquez-Contreras4,
  • Perla D. Maldonado2,
  • José Pedraza-Chaverri5 and
  • María Elena Chánez-Cárdenas2Email authorView ORCID ID profile
Biological Research201649:7

DOI: 10.1186/s40659-016-0067-6

Received: 9 September 2015

Accepted: 14 January 2016

Published: 1 February 2016

Abstract

Background

Aged garlic extract (AGE) and its main constituent S-allylcysteine (SAC) are natural antioxidants with protective effects against cerebral ischemia or cancer, events that involve hypoxia stress. Cobalt chloride (CoCl2) has been used to mimic hypoxic conditions through the stabilization of the α subunit of hypoxia inducible factor (HIF-1α) and up-regulation of HIF-1α-dependent genes as well as activation of hypoxic conditions such as reactive oxygen species (ROS) generation, loss of mitochondrial membrane potential and apoptosis. The present study was designed to assess the effect of AGE and SAC on the CoCl2-chemical hypoxia model in PC12 cells.

Results

We found that CoCl2 induced the stabilization of HIF-1α and its nuclear localization. CoCl2 produced ROS and apoptotic cell death that depended on hypoxia extent. The treatment with AGE and SAC decreased ROS and protected against CoCl2-induced apoptotic cell death which depended on the CoCl2 concentration and incubation time. SAC or AGE decreased the number of cells in the early and late stages of apoptosis. Interestingly, this protective effect was associated with attenuation in HIF-1α stabilization, activity not previously reported for AGE and SAC.

Conclusions

Obtained results show that AGE and SAC decreased apoptotic CoCl2-induced cell death. This protection occurs by affecting the activity of HIF-1α and supports the use of these natural compounds as a therapeutic alternative for hypoxic conditions.

Keywords

Aged garlic extract Chemical hypoxia Cobalt chloride Hypoxia-inducible factor 1 PC12 cells S-allylcysteine

Background

Hypoxia is a component of physiological events and multiple pathophysiological conditions, including neonatal hypoxia, cerebral ischemia, peripheral vascular disease, myocardial infarction, coronary heart disease and cancer [1, 2]. Hypoxic stress to cells alters gene expression regulation, leading to subsequent recovery processes or cell death. Hypoxia-inducible factor 1 (HIF-1) is the master regulator of oxygen homeostasis, and adaptive cellular responses to reduced oxygen availability are primarily regulated by the stabilization/degradation ratio of the α subunit of the transcription factor HIF-1 [35].

Cobalt chloride (CoCl2) has been widely used to imitate hypoxic conditions both in vivo [6, 7] and in vitro [8, 9]. CoCl2 mimics several aspects of the hypoxic response, such as increasing and stabilizing HIF-1α protein through inhibition of Prolyl Hydroxylases (PHDs) activity and producing reactive oxygen species (ROS), which leads to cell damage, decreased cell viability and apoptosis [911]. Previous studies have clearly shown that CoCl2-induced cell damage is associated with an increase in ROS that subsequently induces apoptosis. Apoptotic morphology, DNA fragmentation, activation of caspases -3 and -9, loss of mitochondrial membrane potential, cytochrome c release, upregulation of Bax and down-regulation of Bcl2, [8, 9, 1216] as well as p38MAPK activation [13] has been observed as result of CoCl2 induced damage.

The current study assessed the mechanism of action and protective effect of two antioxidant garlic derivatives, aged garlic extract (AGE) and S-allylcysteine (SAC), on hypoxia-induced damage.

AGE is the result of prolonged (20 months) garlic extraction in 20 % ethanol. This aging process converts unstable and odorous compounds into odorless and stable forms [17, 18]. The most abundant organosulfur compound in AGE is SAC (0.6 mg/g product); however, other AGE compounds, such as S-allylmercaptocysteine, alliin, Nα-(1-deoxy-D-fructos-1-yl)-l-arginine and tetrahydro-beta-carbolines, have been shown to inhibit oxidizing events and to scavenge free radicals and oxidant species such as hydroxyl radicals (OH), superoxide anions (O2 •-) and hydrogen peroxide (H2O2). The evidence shows that AGE can ameliorate the oxidative damage implicated in aging and a variety of diseases, including cardiovascular alterations, cancer, stroke, Alzheimer’s disease, and other age-related degenerative conditions (reviewed in [19]). The protective effect of AGE in different models has been associated with its antioxidant properties [2022], reviewed in [23].

SAC is the best characterized AGE compound. It is formed by γ-glutamyl-S-allylcysteine catabolism and has been used to standardize commercial AGE [24]. Previous studies have shown that SAC scavenges O2 [25], H2O2, OH, peroxynitrite anions, hypochlorous acid, singlet oxygen and peroxyl radicals [25, 26]. It also prevents H2O2-induced peroxidation and H2O2-induced activation of NFκB. SAC administration increases glutathione levels as well as catalase and glutathione peroxidase activities [19].

CoCl2-treated PC12 cells have been used to study the mechanisms underlying cell death due to hypoxia/ischemia conditions because they are particularly sensitive to hypoxic changes and reproduce apoptotic cell death [8, 9, 1214]. We investigated the effect of AGE and SAC on cell death to determine the mechanisms behind CoCl2-induced injuries in PC12 cells. Our results showed that the protective effect of SAC and AGE was due to the preservation of cell viability and a decrease in cell death, particularly CoCl2-induced apoptosis. Our observations suggest that this increased cell survival occurs through the attenuation of HIF-1α stabilization and binding activity via the direct antioxidant effects of AGE and SAC.

Results

CoCl2 affects cell viability in a concentration- and time-dependent manner

Concentration- and time-dependent changes in MTT reduction were used to assess CoCl2-induced effects. Cells were incubated for 24 or 48 h at increasing concentrations of CoCl2. Concentration- and time-dependent decreases in cell viability were observed. A significant reduction was observed at 0.5 mM CoCl2 for both time periods tested (Fig. 1a). The lowest cell viability percentage was observed after 24-h incubation with 1.0 mM CoCl2 (50 %). At 48 h, a 50 % MTT reduction was observed after exposure between 0.4 and 0.6 mM CoCl2. Representative bright field micrographs of cells at 0 (vehicle), 0.5 and 1.0 mM CoCl2 at 24 or 48 h are shown in Fig. 1b. Time-dependent cell shrinkage and irregular shapes were found in cells treated with 0.5 and 1.0 mM CoCl2. These data are consistent with the MTT reduction results.
Fig. 1

Effect of CoCl2 on cell viability. Cells were incubated for 24 or 48 h at increasing CoCl2 concentrations (0.1–1.0 mM). After incubation, (a) the MTT reduction was determined, and (b) representative phase-contrast micrographs showing the effect of CoCl2 on cell morphology were taken. Data are shown as the mean ± S.E.M, n = 3–4. One-way ANOVA followed by Dunnett’s test. *p < 0.05 and **p < 0.01 vs. 0 mM (control)

CoCl2 stabilizes HIF-1α and increases binding to hypoxia response elements (HRE) sequence

The binding of stabilized HIF-1α was determined using ELISA (Fig. 2). The binding of nuclear HIF-1α to HRE sequence was increased by approximately 6- and 4-fold after a 24-h exposure to 0.5 and 1.0 mM CoCl2, respectively. CoCl2 incubation for 48 h induced further increases of 19- and 35-fold after exposure to 0.5 and 1.0 mM CoCl2, respectively. No signal was detected in cells incubated with 0.15 mM CoCl2 for 30 min or 1 h (data not shown). Based on these results and the MTT data (Fig. 1), we used exposure to 0.5 and 1.0 mM CoCl2 for 24 or 48 h for subsequent experiments.
Fig. 2

Effect of CoCl2 on HIF-1α stabilization and binding activity. Cells were incubated for 24 or 48 h with 0.5 or 1.0 mM CoCl2. Binding of nuclear HIF-1α to HRE sequences was determined using an ELISA. Data are shown as the mean ± S.E.M, n = 3. Two-way ANOVA followed by Bonferroni comparisons. *p < 0.05 and **p < 0.001 vs. vehicle at the same time point, #p < 0.001 vs. 0.5 mM CoCl2 at the same time point

SAC and AGE prevent CoCl2-induced toxicity

To determine the effect of SAC and AGE on CoCl2-induced toxicity, cells were co-incubated with SAC or AGE and CoCl2 for 24 or 48 h as stated in the experimental design. The level of MTT reduction was determined. Concentrations of 5 or 10 mM SAC and 0.5 or 1.0 % AGE were chosen based on previous in vitro reports (SAC: [27, 28]; AGE: [29, 30]) and toxicity experiments using SAC (0–20 mM) or AGE (0–1 %) for 24 and 48 h (data not shown). After 24 h, 0.5 mM CoCl2 reduced cell viability to 60 %, and co-incubation with SAC (5 or 10 mM) completely restored cell viability (Fig. 3a). Similar results were obtained with AGE, including a partial increase in cell viability after treatment with 0.5 % AGE and almost complete prevention with 1.0 % AGE after cells were incubated with 0.5 mM CoCl2 (Fig. 3b). Neither SAC (Fig. 3a) nor AGE (Fig. 3b) exhibited a significant protective effect on the toxicity induced by 1.0 mM CoCl2. The toxicity induced by 0.5 mM or 1.0 mM CoCl2 for 48 h was clearly prevented by co-incubation with either SAC (Fig. 3c) or AGE (Fig. 3d). Based on these results, subsequent experiments were conducted using 10 mM SAC and 1 % AGE for 48 h.
Fig. 3

Effect of SAC and AGE on CoCl2-induced toxicity in PC12 cells. Cells were co-incubated with CoCl2 and either SAC or AGE for 24 (a and b) or 48 h (c and d). Data are shown as the mean ± S.E.M. n = 4. Two-way ANOVA followed by Bonferroni comparisons. *p < 0.05, **p < 0.01 and ***p < 0.001 vs. vehicle and #p < 0.05, ##p < 0.01 and ###p < 0.001 vs. the same concentration of CoCl2

SAC and AGE prevent cell death induced by CoCl2

To further investigate the effect of SAC and AGE on CoCl2-induced cell death, we monitored the cell cycle profile using fluorescence-activated cell sorting (FACS) analysis (Fig. 4). The fraction of cells in the Sub-G0 phase increased from 3 to 22 % after exposure to 0.5 mM CoCl2 for 48 h and 39 % after exposure to 1.0 mM CoCl2 (compared to vehicle). Both SAC and AGE prevented this increase. Co-incubation with SAC and AGE reduced the 0.5 mM CoCl2-induced cell death to 5 and 8 %, respectively. Cells exposed to 1.0 mM CoCl2 and SAC or AGE showed a decrease in cell death from 39 to 17 and 20 %, respectively.
Fig. 4

Effect of SAC or AGE co-incubation with CoCl2 on the Sub-G0 peak. Cells were co-incubated with 10 mM SAC or 1 % AGE and 0.5 or 1.0 mM CoCl2 for 48 h. Sub-G0 data were obtained using flow cytometry with cells incubated with PI. Data are shown as the mean ± S.E.M. n = 4–5. Two-way ANOVA followed by Bonferroni comparisons.*p < 0.01 and **p < 0.001 vs. control cells (vehicle), #p < 0.01 vs. the same concentration of CoCl2

SAC and AGE prevent CoCl2-induced apoptosis

The Annexin V/7-AAD staining in Fig. 5 shows the effect of CoCl2 and SAC or AGE on cell death. Representative figures are shown in Fig. 5 (a–f). The analysis of six independent experiments is shown in Fig. 5 (g–j). In agreement with the MTT reduction and Sub-G0 peak results, SAC and AGE prevented CoCl2- induced cell death. The known apoptosis inducer in PC12 cells staurosporine (200 nM) was used as a positive control (Additional file 1: Figure S1). The percentage of live cells at 0.5 mM CoCl2 was 22 %, and co-incubation with SAC or AGE increased cell viability to 50 %. Co-incubation of cells with 1.0 mM CoCl2 and SAC or AGE prevented cell death and increased the percentage of live cells from 8 to 30 and 40 %, respectively (Fig. 5h). Single 7-AAD + cells were less than 10 % for both CoCl2 concentrations (Fig. 5g). Early apoptotic cells (single Annexin +) increased from 15 % to approximately 50 % after exposure to 0.5 mM CoCl2. This increase was prevented by co-incubation with SAC (to 20 %) or AGE (to 25 %) (Fig. 5i). In addition, 1.0 mM CoCl2 induced an increase in Annexin +/7-AAD + cells from 15 % to approximately 60 %, and both SAC and AGE attenuated this effect to 35 and 18 %, respectively (Fig. 5 j).
Fig. 5

Protective effect of SAC and AGE on CoCl2-induced apoptosis. Upper panel: Representative figures of Annexin and 7-AAD double staining assay using flow cytometry after 48-h incubation with CoCl2 and SAC or AGE (af). Percentage of 7-AAD + (g), live Annexin-/7AAD- (h), early apoptotic Annexin +/7AAD- (i) and late apoptotic plus necrotic cells Annexin +/7AAD + (j). Data are shown as the mean ± S.E.M. n = 6. Two-way ANOVA followed by Bonferroni comparisons. *p < 0.05, **p < 0.001 vs. control cells (vehicle), #p < 0.05, ##p < 0.01 vs. the same concentration of CoCl2

SAC and AGE decrease CoCl2-induced ROS generation

In addition to the increase in HIF-1α protein stabilization, CoCl2 mimics other hypoxia responses, including ROS generation. Figure 6a shows the increase in the 2’, 7’dichlorofluorescein (DCF)-derived fluorescence of cells exposed for 1 h to 0.5 and 1.0 mM CoCl2 (vehicle bars). Co-incubation with 10 mM SAC or 1 % AGE decreased the ROS generated from exposure to both CoCl2 concentrations.
Fig. 6

SAC and AGE attenuates CoCl2-induced overproduction of ROS and HIF-1α stabilization and binding activity. a Cells were incubated with CoCl2 and SAC or AGE to determine intracellular ROS levels. Data are shown as the mean ± S.E.M. n = 6. *p < 0.001 vs. vehicle. #p < 0.05, ##p < 0.01 and ###p < 0.001 vs. the same concentration of CoCl2. b Binding of stabilized HIF-1α to HRE sequences was determined using an ELISA. Data are shown as the mean ± S.E.M. n = 3. Two-way ANOVA followed by Bonferroni comparisons. *p < 0.001 vs. vehicle; #p < 0.001 vs. the same concentration of CoCl2

SAC and AGE decrease CoCl2-induced HIF-1α stabilization and binding to HRE sequence

The effect of SAC and AGE on nuclear HIF-1α stabilization and binding to HRE sequences was tested using an ELISA. A significant increase in the HIF-1α signal was observed at 0.5 and 1.0 mM CoCl2 (20- and 35-fold, respectively), and SAC and AGE prevented the increase in HIF-1α. Exposure to 0.5 mM CoCl2 decreased HIF-1α binding activity from 20-fold to 3-fold with SAC and 7-fold with AGE. At 1.0 mM CoCl2, HIF-1α activity decreased from 35-fold to 13-fold and 19-fold with SAC or AGE, respectively (Fig. 6b).

Discussion

The cellular injury caused by hypoxia is involved in pathological events, such as cerebral ischemia, neonatal hypoxia and cancer. Thus, it is relevant to explore the mechanisms underlying the potential protective effects of compounds through hypoxia models.

The chemical hypoxia model induced by CoCl2 exposure in PC12 cells is a useful in vitro model to elucidate the mechanisms behind hypoxia damage and test novel compounds because it reproduces many hypoxic conditions, including ROS generation, mitochondrial membrane potential changes, induction of apoptosis [1216] and HIF-1α-regulated transcriptional responses [8, 9]. In this study, we observed that exposure to 0.5 and 1.0 mM CoCl2 for 24 or 48 h induced the stabilization and translocation of HIF-1α to the nucleus, confirming that CoCl2 can mimic hypoxia in PC12 cells [8, 15].

This study was designed to determine the effect of two garlic-derived antioxidants, AGE and SAC, in PC12 cells subjected to chemical hypoxia induced by CoCl2. We observed that co-incubation of AGE or SAC with CoCl2 exerted a protective effect against the CoCl2-induced cell viability decrease. In the case of 1.0 mM CoCl2, it was clearly evident only after longer periods of exposure (48 h). Cell function was almost completely recovered for SAC or AGE co-incubation with 0.5 mM CoCl2 at both tested times. In contrast, 1.0 mM CoCl2 had a pronounced toxicity effect that results in an apparent lack of protection at both SAC and AGE concentrations tested at 24 h (Fig. 3a, b). Interestingly, a protective effect exerted by SAC and AGE was observed at 48 h, with a significant recovery of the cell viability at 1.0 mM CoCl2 (Fig. 3c, d). Noteworthy, about the same percentage of viable cells observed at 24 h with SAC and AGE treatment was maintained at 48 h. It suggests that both compounds retain cell viability along time. The marked decrease of cell viability in vehicle treated cells (48 h compared to 24 h) evidences this protective effect. SAC and AGE did not show a dose dependent effect, probably because the recovery of cell function at 5 mM SAC or 0.5 % AGE is the maximum recovery we could obtain for the 1.0 mM CoCl2-induced damage in PC12 cells. We suggest that protective mechanisms of both SAC and AGE may depend on the severity of the stimulus, which could trigger different molecular responses, such as the differences observed in HIF-1α activity at both CoCl2 concentrations (Fig. 2).

The decrease in Sub-G0 values after treatment with SAC or AGE confirmed this protection. This technique allows quantification of the number of cells through DNA fragmentation. To differentiate early apoptotic cells, we performed flow cytometry with Annexin V/7-AAD double staining. Sub-G0 results were corroborated by the Annexin V-7AAD assay, and a significant preservation of the number of live cells was observed after AGE or SAC treatment. Although this assay does not distinguish between late apoptotic and necrotic cells since both of them are Annexin and 7-AAD positive (Q2: Annexin +/7-AAD +), previous characterization of CoCl2-induced cell death strongly suggest that the cells in Q2 are mainly apoptotic. In addition, we used another well-known apoptotic inducer in PC12 cells (Additional file 1: Figure S1). As expected, and in accordance to CoCl2 effect, cells are mainly distributed in Q2 and Q3 in response to staurosporine 200 nM. Since we strictly cannot differentiate necrotic cells, we labeled Q2 as late apoptotic and necrotic cells. Observed cell death depended on the CoCl2 concentration and incubation time; furthermore, SAC or AGE decreased the number of cells in early apoptosis as well as in late stages of apoptosis (plus possible necrotic cells).

AGE and SAC attenuated HIF-1α stabilization and binding to HRE sequences, suggesting a direct effect on the transcriptional activity of HIF-1α. Several reports suggest that ROS induces HIF-1α protein stabilization [31, 32]. It has been reported that ROS activates the HIF-1α promoter via a NFκB site, suggesting that these factors are important in disorders that show increased levels of ROS [33]; in addition, the effects of ROS on HIF-1α can also be affected by the degree of hypoxia, the form and intracellular location of ROS produced during hypoxia and the molecular microenvironment of the cell [34]. Under hypoxic conditions, mitochondrial complex III may produce ROS, and the presence of high ROS concentrations generated from the mitochondria has been shown to stabilize HIF-1α [3538]. However, it has been suggested that mitochondrial-independent mechanisms are primarily responsible for CoCl2-induced ROS generation and the activation of HIF-1α [10, 11]. However, the generation of ROS could also be due to NADPH oxidases in the cytosol. Regardless, ROS influence HIF-1α activity. We observed that a decrease in activated HIF-1α correlates with a decrease in CoCl2-induced ROS after SAC or AGE treatment. There are several hypotheses that can explain the stabilization of HIF-1α expression by ROS: 1) Fe2+ oxidation by H2O2 affects PHDs activity; 2) prevention of Fe3+ reduction by ascorbate; 3) prevention of ascorbate from binding to PHDs; 4) or a ROS-induced change in O2 availability that affects HIF binding to PHDs [34]. The concentrations of CoCl2 used in our study have been shown to induce oxidant stress in cells and oxidize intracellular ascorbate [39], confirming that ROS affects HIF-1α stability.

Thus, SAC and AGE prevent HIF-1α activation due to their antioxidant nature, which leads to a decrease in apoptotic cell death. The antioxidant effect of SAC and AGE on HIF-1α activity has not been described to date. A reduction in HIF-1α levels has also resulted in protection in other models [14, 3941]. The reduction of cell death by blocking HIF-1α stabilization may be due to the inability of HIF-1α to induce the transcription of proapoptotic members of the Bcl2 BH3-only family that induce oxidative death, such as BNIP3, PUMA and NOXA [4244]. Hence, the prevention of apoptotic cell death by SAC and AGE can be explained by the abrogation of HIF-mediated transactivation of BH3-only proteins [42].

In summary, we observed a protective effect of AGE and SAC on CoCl2 toxicity after CoCl2 exposure. The cell viability was preserved by AGE or SAC co-incubation. Flow cytometry showed that both garlic-derived antioxidants decreased the number of dead cells and a decrease in early and late apoptotic cell death after AGE or SAC treatment, depending on the CoCl2 concentration and incubation time used. Both garlic derivatives decreased HIF-1α stabilization and nuclear translocation, suggesting that their antioxidant role directly affects the transcriptional activity of HIF-1α and subsequently blocks the transcription of prodeath HIF-1α regulated genes.

Conclusions

HIF modulation is an attractive strategy for the therapeutic intervention of pathological conditions affected by hypoxia and for the study of hypoxic mechanisms; however, fundamental studies are required before testing in clinical trials. We suggest that the use of SAC or AGE is a plausible strategy to minimize the prodeath effects of HIF-1α and the consequent cell death associated with hypoxia and oxidative stress conditions. However, further research is necessary to elucidate the exact signaling pathways involved. The mechanisms behind apoptosis and its relationship with HIF-1α activity can be used to translate the full potential of AGE and SAC into a preventive strategy to counteract hypoxic consequences.

Methods

Materials

All reagents were analytical grade and commercially available. AGE Kyolic® was obtained from Wakunaga of America Co. (Ltd, Mission Viejo, CA, USA). This garlic extract complies with the specifications established in the US Pharmacopeia/National Formulary [24].

Synthesis of S-allylcysteine (SAC)

SAC was synthesized by the reaction of l-cysteine with allyl bromide and purified by recrystallization from an ethanol–water solution. The final product was compared with a SAC standard using thin layer chromatography, high performance liquid chromatography, 1H nuclear magnetic resonance (NMR), infra-red and electronic ionization-mass spectroscopy (EI-MS). A detailed procedure for SAC synthesis, purification and identification of the final chemical compound are reported in [26]. The melting point of the SAC standard is 220–222 °C, and the melting point of the SAC used in this study was 218–219 °C. The analysis of the final product by high performance liquid chromatography showed one peak with a retention time of 12.38 min.

Cell culture

PC12 cells were obtained from the American Type Culture Collection (Rockville, MD, USA). Cells were routinely cultured in Dulbecco’s modified Eagle’s Medium (DMEM) with 7.5 % heat-inactivated horse serum and 7.5 % fetal bovine serum at 37 °C in a humidified atmosphere of 5 % CO2/95 % air [14]. Cells were seeded at a density of 7.5 × 104 cells/cm2. For experiments, confluent cultures were maintained in DMEM free of serum.

Experimental design

Cells were incubated for 24 or 48 h at 37 °C in one of the following conditions: vehicle (DMEM free of serum); SAC (5 or 10 mM); AGE (0.5 or 1.0 %); CoCl2 (0.5 or 1.0 mM); CoCl2 0.5 mM plus SAC (5 or 10 mM); CoCl2 1.0 mM plus SAC (5 or 10 mM); CoCl2 0.5 mM plus AGE (0.5 or 1.0 %); or CoCl2 1.0 mM plus AGE (0.5 or 1.0 %). Cells were harvested and used to evaluate HIF-1α activation, cell viability and Sub-G0 levels using an enzyme-linked immunosorbent assay (ELISA), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assay and Annexin V/7-aminoactinomycin D (7-AAD) double staining with flow cytometry, respectively. Intracellular ROS levels were determined using 2’,7’dichlorofluorescein diacetate (DCFH-DA) in cells incubated for 1 h under the aforementioned conditions.

Cell viability assay

Cell viability was assessed using a MTT reduction assay as previously reported [14]. MTT (0.5 mg ml−1) was added to each well, and cells were incubated at 37 °C for 1.5 h. The formazan blue product was spectroscopically quantified at 570 nm. Data are expressed as the percentage of MTT reduction compared to control wells. The data were confirmed by bright field micrographs.

HIF-1α activity assay

Cell nuclear fractions were obtained using a NE-PER® Nuclear and Cytoplasmic Extraction Reagents kit, (PIERCE, Thermo Scientific, Rockford, IL, USA), and the protein concentration was determined. Stabilized HIF-1α bound to the HRE sequence was determined using an ELISA-HIF-1α activity Transcription Factor Assay Kit (Cayman Chemical Co. Ann Arbor, MI, USA) according to the manufacturer’s instructions. The results are expressed as OD 450 nm/µg protein.

Flow cytometry

Based on the methods of [45], FACS analysis was used to determine the Sub-G0 peak and the level of apoptosis after staining with propidium iodide (PI) or Annexin V and 7-AAD, respectively. A total of 10,000 events were evaluated, and data were collected on a FACSCalibur instrument (BD Biosciences, Franklin Lakes, NJ, USA). Data analysis was conducted using Cell QuestPro and Flow Jover 7.6.1 software.

Reactive oxygen species measurement

Intracellular ROS levels were determined by the oxidative conversion of DCFH-DA to DCF. PC12 cells were cultured in 6-well plates. Cells were incubated for 1 h using the previously described treatment conditions. Cells were washed twice with PBS, and the 10 µM DCFH-DA in serum-free medium was added. Next, cells were incubated for 30 min at 37 °C in the dark. Cells were washed twice with PBS, lysed in phosphate buffer (50 mM pH 7.4, 1 % v/v Triton X-100) and centrifuged for 20 min at 12,000g. The fluorescence intensity was determined at excitation/emission wavelengths of 488 nm/515 nm. Micromoles of DCF were determined with a DCF calibration curve.

Statistical analyses

Data are expressed as the mean ± S.E.M. and were analyzed using Prism 5 software (GraphPad, San Diego, CA, USA), applying analysis of variance (ANOVA) followed by the Bonferroni Multiple Comparison test or Dunnett’s test, as appropriate. A value of p < 0.05 was considered significant.

Abbreviations

DCFH-DA: 

2’,7’dichlorofluorescein diacetate

DCF: 

2’, 7’dichlorofluorescein

MTT: 

3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide

7-AAD: 

7-Aminoactinomycin D

AGE: 

aged garlic extract

ANOVA: 

analysis of variance

CoCl2

cobalt chloride

DMEM: 

Dulbecco’s modified eagle’s medium

ELISA: 

enzyme-linked immunosorbent assay

H2O2

hydrogen peroxide

HIF-1: 

hypoxia inducible factor

HRE: 

hypoxia response elements

O2

oxygen

PI: 

propidium iodide

ROS: 

reactive oxygen species

SAC: 

S-allylcysteine

Declarations

Authors’ contributions

M.O-I.; J.M-S., M.Z-M., B.P.; R.M–M. and M.E.C–C. Conducted research: Experiments and data collection. M.O-I. Analyzed data and performed statistical analysis. M.O-I.; E V-C; J. P–C and P. M.: Provided essential reagents and material. E V-C; P. M; J. P–C and M.E.C–C: Study oversight and development of overall research., M.E.C–C: Designed research: Project conception; development of overall research plan. Analyzed data and wrote paper. All authors read and approved the final manuscript.

Acknowledgements

This work was supported in part by PAPIIT IN2i0713 and CONACYT 220046, 168356, 129838, 252008 and ICYTDF/229/2012. Martín E. Zavala-Medina received a scholarship from the Armstrong Foundation in México. Jorge Muñoz-Sánchez acknowledges the scholarship and financial support provided by the National Council of Science and Technology (CONACYT) and the National Autonomous University of Mexico (UNAM).

Competing interests

All authors declare that they have no competing interest.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Laboratorio de Neurobiología Molecular y Celular, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez
(2)
Laboratorio de Patología Vascular Cerebral, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez
(3)
Laboratorio de Neuroinmunología y Neuro-oncología, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez
(4)
Departamento de Ciencias Naturales, CNI, Universidad Autónoma Metropolitana Cuajimalpa
(5)
Departamento de Biología, Facultad de Química, Universidad Nacional Autónoma de México, Ciudad Universitaria

References

  1. Brahimi-Horn MC, Chiche J, Pouyssegur J. Hypoxia signalling controls metabolic demand. Curr Opin Cell Biol. 2007;19:223–9.View ArticlePubMedGoogle Scholar
  2. Lendahl U, Lee KL, Yang H, Poellinger L. Generating specificity and diversity in the transcriptional response to hypoxia. Nat Rev Genet. 2009;10:821–32.View ArticlePubMedGoogle Scholar
  3. Semenza GL. HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol. 2001;13:167–71.View ArticlePubMedGoogle Scholar
  4. Rocha S. Gene regulation under low oxygen: holding your breath for transcription. Trends Biochem Sci. 2007;32:389–97.View ArticlePubMedGoogle Scholar
  5. Semenza GL. Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu Rev Pathol. 2014;9:47–71.View ArticlePubMedGoogle Scholar
  6. Caltana L, Merelli A, Lazarowski A, Brusco A. Neuronal and glial alterations due to focal cortical hypoxia induced by direct cobalt chloride (CoCl2) brain injection. Neurotox Res. 2009;15:348–58.View ArticlePubMedGoogle Scholar
  7. Kalpana S, Dhananjay S, Anju B, Lilly G. Sai Ram M. Cobalt chloride attenuates hypobaric hypoxia induced vascular leakage in rat brain: molecular mechanisms of action of cobalt chloride. Toxicol Appl Pharmacol. 2008;231:354–63.View ArticlePubMedGoogle Scholar
  8. Lan A, Liao X, Mo L, Yang C, Yang Z, Wang X, Hu F, Chen P, Feng J, Zheng D, Xiao L. Hydrogen sulfide protects against chemical hypoxia-induced injury by inhibiting ROS-activated ERK1/2 and p38MAPK signaling pathways in PC12 Cells. PLoS One. 2011;6:e25921.View ArticlePubMed CentralPubMedGoogle Scholar
  9. Lan AP, Xiao LC, Yang ZL, Yang CT, Wang XY, Chen PX, Gu MF, Feng JQ. Interaction between ROS and p38MAPK contributes to chemical hypoxia-induced injuries in PC12 cells. Mol Med Report. 2012;5:250–5.Google Scholar
  10. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker PT. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci. 1998;95:11715–20.View ArticlePubMed CentralPubMedGoogle Scholar
  11. Hamanaka RB, Chandel NS. Mitochondrial reactive oxygen species regulate hypoxic signaling. Curr Opin Cell Biol. 2009;21:894–9.View ArticlePubMed CentralPubMedGoogle Scholar
  12. Jung JY, Kim WJ. Involvement of mitochondrial- and Fas-mediated dual mechanism in CoCl2-induced apoptosis of rat PC12 cells. Neurosci Lett. 2004;371:85–90.View ArticlePubMedGoogle Scholar
  13. Zou W, Zeng J, Zhuo M, Xu W, Sun L, Wang J, Liu X. Involvement of caspase-3 and p38 mitogen-activated protein kinase in cobalt choride-induced apoptosis in PC12 cells. J Neurosci Res. 2002;67:837–43.View ArticlePubMedGoogle Scholar
  14. Guo LX, Liu JH, Xia ZN. Geniposide inhibits CoCl2-induced PC12 cells death via the mitochondrial pathway. Chin Med J (Engl). 2009;122:2886–92.Google Scholar
  15. Wang G, Hazra TK, Mitra S, Lee HM, Englander EW. DNA damage and a hypoxic response are induced by CoCl2 in rat neuronal PC12 cells. Nucleic Acids Res. 2000;28:2135–40.View ArticlePubMed CentralPubMedGoogle Scholar
  16. Jung JY, Roh KH, Jeong YJ, Kim SH, Lee EJ, Kim MS, Oh WM, Oh HK, Kim WJ. Estradiol protects PC12 cells against CoCl2-induced apoptosis. Brain Res Bull. 2008;76:579–85.View ArticlePubMedGoogle Scholar
  17. Amagase H, Petesch BL, Matsuura H, Kasuga S, Itakura Y. Intake of garlic and its bioactive components. J Nutr. 2001;131:955S–62S.PubMedGoogle Scholar
  18. Lawson LD. The composition and chemistry of garlic cloves and processed garlic. In: Koch HP, Lawson LD, editors. The Science and Therapeutic Application of Allium sativum L. and Related Species. Baltimore: Williams and Wilkins; 1996. p. 37–107.Google Scholar
  19. Colín-González AL, Santana RA, Silva-Islas CA, Chánez-Cárdenas ME, Santamaria A, Maldonado PD. The antioxidant mechanisms underlying the effects of aged garlic extract and S-allylcysteine-induced protection. Oxid Med Cell Longev. 2012;2012:907162.View ArticlePubMed CentralPubMedGoogle Scholar
  20. Numagami Y, Sato S, Ohnishi ST. Attenuation of rat ischemic brain damage by aged garlic extracts: a possible protecting mechanism as antioxidants. Neurochem Int. 1996;29:135–43.View ArticlePubMedGoogle Scholar
  21. Aguilera P, Chánez-Cárdenas ME, Ortiz-Plata A, León-Aparicio D, Barrera D, Espinoza-Rojo M, Villeda-Hernández J, Sánchez-García A, Maldonado PD. Aged garlic extract delays the appearance of infarct area in a cerebral ischemia model, an effect likely conditioned by the cellular antioxidant systems. Phytomedicine. 2010;17:241–7.View ArticlePubMedGoogle Scholar
  22. Colín-González AL, Ortiz-Plata A, Villeda-Hernández J, Barrera D, Molina-Jijón E, Pedraza-Chaverrí J, Maldonado PD. Aged garlic extract attenuates cerebral damage and cyclooxygenase-2 induction after ischemia and reperfusion in rats. Plant Foods Hum Nutr. 2011;66:348–54.View ArticlePubMedGoogle Scholar
  23. Maldonado PD, Limón D, Galván-Arzate S, Santamaria A. Pedraza-Chaverrí J Medicinal properties of garlic: importance of its antioxidant activity. In: Pãcurar M, Krejci G, editors. Garlic Consumption and Health. New York: Nova Science Publisher Inc; 2009. p. 61–116.Google Scholar
  24. Aged Garlic Extract, 2006. Research excerpts from peer reviewed scientific journals and scientific meetings. Wakunaga of America Co. Ltd., Mission Viejo, p. 1.
  25. Medina-Campos ON, Barrera D, Segoviano-Murillo S, Rocha D, Maldonado PD, Mendoza-Patiño N, Pedraza-Chaverri J. S-allylcysteine scavenges singlet oxygen and hypochlorous acid and protects LLC-PK(1) cells of potassium dichromate-induced toxicity. Food Chem Toxicol. 2007;45:2030–9.View ArticlePubMedGoogle Scholar
  26. Maldonado PD, Alvarez-Idaboy JR, Aguilar-González A, Lira-Rocha A, Jung-Cook H, Medina-Campos ON, Pedraza-Chaverri J, Galano A. Role of allyl group in the hydroxyl and peroxyl radical scavenging activity of S-allylcysteine. J Phys Chem B. 2011;115:13408–17.View ArticlePubMedGoogle Scholar
  27. Ho SE, Ide N, Lau BH. S-allyl cysteine reduces oxidant load in cells involved in the atherogenic process. Phytomedicine. 2001;8:39–46.View ArticlePubMedGoogle Scholar
  28. Kosuge Y, Koen Y, Ishige K, Minami K, Urasawa H, Saito H, Ito Y. S-allyl-l-cysteine selectively protects cultured rat hippocampal neurons from amyloid beta-protein and tunicamycin-induced neuronal death. Neurosci. 2003;122:885–95.View ArticleGoogle Scholar
  29. Velasco-Velázquez MA, Maldonado PD, Barrera D, Torres V, Zentella-Dehesa A, Pedraza-Chaverrí J. Aged garlic extract induces proliferation and ameliorates gentamicin-induced toxicity in LLC-PK1 cells. Phytother Res. 2006;20:76–8.View ArticlePubMedGoogle Scholar
  30. Berginc K, Trontelj J, Kristl A. The influence of aged garlic extract on the uptake of saquinavir and darunavir into HepG2 cells and rat liver slices. Drug Metab Pharmacokinet. 2010;25:307–13.View ArticlePubMedGoogle Scholar
  31. Jusman SW, Halim A, Wanandi SI, Sadikin M. Expression of hypoxia-inducible factor-1alpha (HIF-1alpha) related to oxidative stress in liver of rat-induced by systemic chronic normobaric hypoxia. Acta Med Indones. 2010;42:17–23.PubMedGoogle Scholar
  32. Deshmane SL, Mukerjee R, Fan S, Del Valle L, Michiels C, Sweet T, Rom I, Khalili K, Rappaport J, et al. Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression. J Biol Chem. 2009;284:11364–73.View ArticlePubMed CentralPubMedGoogle Scholar
  33. Bonello S, Zähringer C, BelAiba RS, Djordjevic T, Hess J, Michiels C, Kietzmann T, Görlach A. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler Thromb Vasc Biol. 2007;27:755–61.View ArticlePubMedGoogle Scholar
  34. Qutub AA, Popel AS. Reactive oxygen species regulate hypoxia-inducible factor 1alpha differentially in cancer and ischemia. Mol Cell Biol. 2008;28:5106–19.View ArticlePubMed CentralPubMedGoogle Scholar
  35. Bell EL, Chandel NS. Mitochondrial oxygen sensing: regulation of hypoxia-inducible factor by mitochondrial generated reactive oxygen species. Essays Biochem. 2007;43:17–27.View ArticlePubMedGoogle Scholar
  36. Bell EL, Klimova TA, Eisenbart J, Moraes CT, Murphy MP, Budinger GRS, et al. The Q(o) site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production. J Cell Biol. 2007;177:1029–36.View ArticlePubMed CentralPubMedGoogle Scholar
  37. Brunelle JK, Bell EL, Quesada NM, Vercauteren K, Tiranti V, Zeviani M, Scarpulla RC, Chandel NS. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab. 2005;1:409–14.View ArticlePubMedGoogle Scholar
  38. Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, Rodriguez AM, Schumacker PT. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J Biol Chem. 2000;275:25130–8.View ArticlePubMedGoogle Scholar
  39. Qiao H, Li L, Qu ZC, May JM. Cobalt-induced oxidant stress in cultured endothelial cells: prevention by ascorbate in relation to HIF-1alpha. BioFactors. 2009;35:306–13.View ArticlePubMed CentralPubMedGoogle Scholar
  40. Han DD, Wang Y, Zhang XH, Liu JR, Wang HL. Fluoxetine protects against monocrotaline-induced pulmonary arterial remodeling by inhibition of hypoxia-inducible factor-1α and vascular endothelial growth factor. Can J Physiol Pharmacol. 2012;90:445–54.View ArticlePubMedGoogle Scholar
  41. Agrawal M, Kumar V, Kashyap MP, Khanna VK, Randhawa GS, Pant AB. Ischemic insult induced apoptotic changes in PC12 cells: protection by trans resveratrol. Eur J Pharmacol. 2011;666:5–11.View ArticlePubMedGoogle Scholar
  42. Aminova LR, Siddiq A, Ratan RR. Antioxidants, HIF prolyl hydroxylase inhibitors or short interfering RNAs to BNIP3 or PUMA, can prevent prodeath effects of the transcriptional activator, HIF-1alpha, in a mouse hippocampal neuronal line. Antioxid Redox Signal. 2008;10:1989–98.View ArticlePubMed CentralPubMedGoogle Scholar
  43. Bruick RK. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci U S A. 2000;97:9082–7.View ArticlePubMed CentralPubMedGoogle Scholar
  44. Kim JY, Ahn HJ, Ryu JH, Suk K, Park JH. BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1α. J Exp Med. 2004;199:113–24.View ArticlePubMed CentralPubMedGoogle Scholar
  45. Orozco-Morales M, Sánchez-García FJ, Guevara-Salazar P, Arrieta O, Hernández-Pedro NY, Sánchez-García A, Perez-Madrigal R, Rangel-López E, Pineda B, Sotelo J. Adjuvant immunotherapy of C6 glioma in rats with pertussis toxin. J Cancer Res Clin Oncol. 2012;138:23–33.View ArticlePubMedGoogle Scholar

Copyright

© Orozco-Ibarra et al. 2016